Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Chubb Ltd (CB) vs Canopy Growth Corp (CGC) Price & Performance

Chubb LtdTrade
Canopy Growth CorpTrade

Price performance (Past 24H)

Key statistics

Chubb Ltd vs Canopy Growth Corp — how do they compare? Chubb Ltd trades at $338.41 (market cap $134.28B), while Canopy Growth Corp trades at $0.97 (market cap $398.46M). The key difference: Chubb Ltd is far larger — about 337× Canopy Growth Corp's market cap, and Chubb Ltd pays a 1.18% dividend while Canopy Growth Corp pays none. Which is the better fit depends on your goals.

CBCGC
Market Cap
$134.28B$398.46M
Sector
FinancialsHealth
52-Week High
$361.17$1.92
52-Week Low
$265.99$0.86
Enterprise Value
$155.34B$337.90M
Dividend Yield
1.18%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Chubb Ltd

Chubb (CB) trades at $354.74, up 1.99% today, with a bullish technical outlook supported by moving averages and strong fundamental performance. Recent earnings beats, including Q1 2026 EPS of $6.82 versus $6.60 expected, highlight robust profitability with a net income margin of 18.46% and ROE of 16.2%. The company maintains disciplined capital deployment, with a recent $1.02 dividend declared for H1 2026.

The stock offers a compelling value with a P/E of 12.55 and consensus price target of $361.67, though near-term risks include catastrophe losses and softer commercial pricing. Long-term growth is supported by premium expansion and investment income, but investors should monitor underwriting margins and market volatility.

Canopy Growth Corp

Canopy Growth (CGC) trades at $0.96, down 1.15% on the day, with a mixed technical picture showing a bullish overall signal but bearish moving averages. The company reported a net loss of $598.12 million in 2025, with revenue declining to $269 million, though recent quarterly earnings showed one beat and two misses against expectations. Cash flow remains negative, but the balance sheet shows improving debt-to-asset ratios, down to 33.13% in 2025 from 53.61% in 2023.

The outlook is cautious; while cost-cutting and restructuring efforts are underway, profitability remains elusive, and the stock faces risks including potential delisting due to low share price. Analyst sentiment is divided, with 33% recommending buy, 41% hold, and 26% sell. Investors should weigh the potential for a turnaround against significant operational and regulatory challenges in the cannabis sector.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Chubb Ltd

ACE acquired Chubb in the first quarter of 2016 and assumed the Chubb name. The combination makes the new Chubb one of the largest domestic property and casualty insurers, with operations in 54 countries spanning commercial and personal P&C insurance, reinsurance, and life insurance.

Read more on CB

About Canopy Growth Corp

Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.

Read more on CGC